Papaverine to reduce perineal injury during vaginal delivery
Part of Women’s health & pregnancy clinical trials.
This trial tests whether papaverine, a medication that relaxes muscles, can reduce tearing and injury to the perineum (the area between the vagina and rectum) during vaginal birth. If it works, it could help first-time mothers heal better after delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- This is your first pregnancy (first-time mothers only)
- You are having a single baby, not multiples
- You are between 37–42 weeks pregnant (full-term)
- Your baby is in head-down position (cephalic presentation)
- You are in active labor with cervix dilated at least 2 cm
- You do not have a heart condition, liver disease, or allergy to papaverine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the pelvic floor (the support muscles and tissues) works in people who had a specific anal sphincter injury during vaginal birth, compared with people who had uncomplicated vaginal deliveries. It may help doctors better understand recovery and function after childbirth injuries.
This study tests a special physiotherapy program for first-time mothers who had a vaginal tear or episiotomy during childbirth. The goal is to see if it helps recovery better than standard care.
This trial compares two techniques (hands-on vs hands-off) used by midwives to protect the perineum during vaginal birth. The goal is to see which method reduces the risk of tears and helps you recover better.
This study tests whether a medicine called papaverine can shorten the pushing phase of labor in women whose labor is started with a balloon catheter. If you are planning a vaginal delivery and meet the other criteria, you may be able to join.
This study tests whether an IV medication called papaverine can help induce labor in pregnant people at term (37+ weeks) whose water has broken but labor hasn't started yet. The goal is to see if this medication makes labor start naturally and reduces the need for cesarean delivery.
This study tests whether adding papaverine, a smooth-muscle relaxant, to the standard labor-inducing drug oxytocin can make labor quicker and safer. It is for first-time mothers carrying a single baby head-down who need to start labor with oxytocin.
Hear when a new Perineal Trauma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.